Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Noninvasive 11C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitis.

Tucker EW, Guglieri-Lopez B, Ordonez AA, Ritchie B, Klunk MH, Sharma R, Chang YS, Sanchez-Bautista J, Frey S, Lodge MA, Rowe SP, Holt DP, Gobburu JVS, Peloquin CA, Mathews WB, Dannals RF, Pardo CA, Kannan S, Ivaturi VD, Jain SK.

Sci Transl Med. 2018 Dec 5;10(470). pii: eaau0965. doi: 10.1126/scitranslmed.aau0965.

PMID:
30518610
2.

Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity: A Translational Approach.

Valenta I, Varga ZV, Valentine H, Cinar R, Horti A, Mathews WB, Dannals RF, Steele K, Kunos G, Wahl RL, Pomper MG, Wong DF, Pacher P, Schindler TH.

JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 2):320-332. doi: 10.1016/j.jcmg.2017.11.019.

PMID:
29413441
3.

Development of a radioligand for imaging V1a vasopressin receptors with PET.

Naik R, Valentine H, Hall A, Mathews WB, Harris JC, Carter CS, Dannals RF, Wong DF, Horti AG.

Eur J Med Chem. 2017 Oct 20;139:644-656. doi: 10.1016/j.ejmech.2017.08.037. Epub 2017 Aug 18.

PMID:
28843869
4.

Chemogenetics revealed: DREADD occupancy and activation via converted clozapine.

Gomez JL, Bonaventura J, Lesniak W, Mathews WB, Sysa-Shah P, Rodriguez LA, Ellis RJ, Richie CT, Harvey BK, Dannals RF, Pomper MG, Bonci A, Michaelides M.

Science. 2017 Aug 4;357(6350):503-507. doi: 10.1126/science.aan2475.

PMID:
28774929
5.

Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer's Disease with Positron Emission Tomography.

Gobbi LC, Knust H, Körner M, Honer M, Czech C, Belli S, Muri D, Edelmann MR, Hartung T, Erbsmehl I, Grall-Ulsemer S, Koblet A, Rueher M, Steiner S, Ravert HT, Mathews WB, Holt DP, Kuwabara H, Valentine H, Dannals RF, Wong DF, Borroni E.

J Med Chem. 2017 Sep 14;60(17):7350-7370. doi: 10.1021/acs.jmedchem.7b00632. Epub 2017 Jul 12.

PMID:
28654263
6.

Quantitative Multi-modal Brain Autoradiography of Glutamatergic, Dopaminergic, Cannabinoid, and Nicotinic Receptors in Mutant Disrupted-In-Schizophrenia-1 (DISC1) Mice.

Kim J, Horti AG, Mathews WB, Pogorelov V, Valentine H, Brasic JR, Holt DP, Ravert HT, Dannals RF, Zhou L, Jedynak B, Kamiya A, Pletnikov MV, Wong DF.

Mol Imaging Biol. 2015 Jun;17(3):355-63. doi: 10.1007/s11307-014-0786-4.

PMID:
25296765
7.

Dose-dependent, saturable occupancy of the metabotropic glutamate subtype 5 receptor by fenobam as measured with [11 C]ABP688 PET imaging.

Mathews WB, Kuwabara H, Stansfield K, Valentine H, Alexander M, Kumar A, Hilton J, Dannals RF, Wong DF, Gasparini F.

Synapse. 2014 Dec;68(12):565-573. doi: 10.1002/syn.21775. Epub 2014 Aug 19.

8.

Modeling of the renal kinetics of the AT1 receptor specific PET radioligand [11C]KR31173.

Gulaldi NC, Xia J, Feng T, Hong K, Mathews WB, Ruben D, Kamel IR, Tsui BM, Szabo Z.

Biomed Res Int. 2013;2013:835859. doi: 10.1155/2013/835859. Epub 2013 Sep 8.

9.

Targeting of endothelin receptors in the healthy and infarcted rat heart using the PET tracer 18F-FBzBMS.

Higuchi T, Rischpler C, Fukushima K, Isoda T, Xia J, Javadi MS, Szabo Z, Dannals RF, Mathews WB, Bengel FM.

J Nucl Med. 2013 Feb;54(2):277-82. doi: 10.2967/jnumed.112.106096. Epub 2013 Jan 11.

10.

Molecular hybrid positron emission tomography/computed tomography imaging of cardiac angiotensin II type 1 receptors.

Fukushima K, Bravo PE, Higuchi T, Schuleri KH, Lin X, Abraham MR, Xia J, Mathews WB, Dannals RF, Lardo AC, Szabo Z, Bengel FM.

J Am Coll Cardiol. 2012 Dec 18;60(24):2527-34. doi: 10.1016/j.jacc.2012.09.023. Epub 2012 Nov 14.

11.

Molecular imaging of the kidneys.

Szabo Z, Alachkar N, Xia J, Mathews WB, Rabb H.

Semin Nucl Med. 2011 Jan;41(1):20-8. doi: 10.1053/j.semnuclmed.2010.09.003. Review.

12.

Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury.

Higuchi T, Fukushima K, Xia J, Mathews WB, Lautamäki R, Bravo PE, Javadi MS, Dannals RF, Szabo Z, Bengel FM.

J Nucl Med. 2010 Dec;51(12):1956-61. doi: 10.2967/jnumed.110.079855. Epub 2010 Nov 15.

13.

Radioligands for the angiotensin II subtype 1 (AT1) receptor.

Mathews WB, Szabo Z.

Curr Top Med Chem. 2010;10(16):1585-99. Review.

PMID:
20583986
14.

Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.

Mathews WB, Murugesan N, Xia J, Scheffel U, Hilton J, Ravert HT, Dannals RF, Szabo Z.

J Nucl Med. 2008 Sep;49(9):1529-36. doi: 10.2967/jnumed.108.051565. Epub 2008 Aug 14.

15.

Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.

McCann UD, Szabo Z, Vranesic M, Palermo M, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA.

Psychopharmacology (Berl). 2008 Oct;200(3):439-50. doi: 10.1007/s00213-008-1218-4. Epub 2008 Jul 27.

16.

Chronic ACE inhibitor treatment increases angiotensin type 1 receptor binding in vivo in the dog kidney.

Zober TG, Fabucci ME, Zheng W, Brown PR, Seckin E, Mathews WB, Sandberg K, Szabo Z.

Eur J Nucl Med Mol Imaging. 2008 Jun;35(6):1109-16. doi: 10.1007/s00259-007-0667-z. Epub 2008 Jan 8.

PMID:
18180920
17.

Positron-emission tomography imaging of the angiotensin II subtype 1 receptor in swine renal artery stenosis.

Xia J, Seckin E, Xiang Y, Vranesic M, Mathews WB, Hong K, Bluemke DA, Lerman LO, Szabo Z.

Hypertension. 2008 Feb;51(2):466-73. doi: 10.1161/HYPERTENSIONAHA.107.102715. Epub 2008 Jan 2.

PMID:
18172054
18.

Radiopharmaceuticals for renal positron emission tomography imaging.

Szabo Z, Xia J, Mathews WB.

Semin Nucl Med. 2008 Jan;38(1):20-31. Review.

PMID:
18096461
19.

Synthesis and in vivo evaluation of a PET radioligand for imaging the endothelin-A receptor.

Mathews WB, Zober TG, Ravert HT, Scheffel U, Hilton J, Sleep D, Dannals RF, Szabo Z.

Nucl Med Biol. 2006 Jan;33(1):15-9.

PMID:
16459254
20.

PET Imaging of the AT1 receptor with [11C]KR31173.

Zober TG, Mathews WB, Seckin E, Yoo SE, Hilton J, Xia J, Sandberg K, Ravert HT, Dannals RF, Szabo Z.

Nucl Med Biol. 2006 Jan;33(1):5-13.

21.

Future direction of renal positron emission tomography.

Szabo Z, Xia J, Mathews WB, Brown PR.

Semin Nucl Med. 2006 Jan;36(1):36-50.

22.

Synthesis and biodistribution of (11)C-GW7845, a positron-emitting agonist for peroxisome proliferator-activated receptor-{gamma}.

Mathews WB, Foss CA, Stoermer D, Ravert HT, Dannals RF, Henke BR, Pomper MG.

J Nucl Med. 2005 Oct;46(10):1719-26.

23.

Synthesis and biodistribution of [11C]adenosine 5'-monophosphate ([11C]AMP).

Mathews WB, Nakamoto Y, Abraham EH, Scheffel U, Hilton J, Ravert HT, Tatsumi M, Rauseo PA, Traughber BJ, Salikhova AY, Dannals RF, Wahl RL.

Mol Imaging Biol. 2005 May-Jun;7(3):203-8.

PMID:
15912424
24.

Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.

McCann UD, Szabo Z, Seckin E, Rosenblatt P, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA.

Neuropsychopharmacology. 2005 Sep;30(9):1741-50.

25.

A novel radioligand for imaging the AT1 angiotensin receptor with PET.

Mathews WB, Yoo SE, Lee SH, Scheffel U, Rauseo PA, Zober TG, Gocco G, Sandberg K, Ravert HT, Dannals RF, Szabo Z.

Nucl Med Biol. 2004 Jul;31(5):571-4.

PMID:
15219274
26.

Positron emission tomography imaging of the serotonin transporter in subjects with a history of alcoholism.

Szabo Z, Owonikoko T, Peyrot M, Varga J, Mathews WB, Ravert HT, Dannals RF, Wand G.

Biol Psychiatry. 2004 Apr 1;55(7):766-71.

PMID:
15039007
27.

In vivo investigation of estrogen regulation of adrenal and renal angiotensin (AT1) receptor expression by PET.

Owonikoko TK, Fabucci ME, Brown PR, Nisar N, Hilton J, Mathews WB, Ravert HT, Rauseo P, Sandberg K, Dannals RF, Szabo Z.

J Nucl Med. 2004 Jan;45(1):94-100.

28.

Positron emission tomography of striatal serotonin transporters in Parkinson disease.

Kerenyi L, Ricaurte GA, Schretlen DJ, McCann U, Varga J, Mathews WB, Ravert HT, Dannals RF, Hilton J, Wong DF, Szabo Z.

Arch Neurol. 2003 Sep;60(9):1223-9.

PMID:
12975287
29.

Carbon-11 labeled radioligands for imaging brain cannabinoid receptors.

Mathews WB, Scheffel U, Rauseo PA, Ravert HT, Frank RA, Ellames GJ, Herbert JM, Barth F, Rinaldi-Carmona M, Dannals RF.

Nucl Med Biol. 2002 Aug;29(6):671-7.

PMID:
12234592
30.

Radiosynthesis and mouse brain distribution studies of [11C] CP-126,998: a PET ligand for in vivo study of acetylcholinesterase.

Musachio JL, Flesher JE, Scheffel UA, Rauseo P, Hilton J, Mathews WB, Ravert HT, Dannals RF, Frost JJ.

Nucl Med Biol. 2002 Jul;29(5):547-52.

PMID:
12088724
31.

Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions.

Szabo Z, McCann UD, Wilson AA, Scheffel U, Owonikoko T, Mathews WB, Ravert HT, Hilton J, Dannals RF, Ricaurte GA.

J Nucl Med. 2002 May;43(5):678-92. Erratum in: J Nucl Med 2002 Jun;43(6):744.

32.

[(11)C]-GR89696, a potent kappa opiate receptor radioligand; in vivo binding of the R and S enantiomers.

Ravert HT, Scheffel U, Mathews WB, Musachio JL, Dannals RF.

Nucl Med Biol. 2002 Jan;29(1):47-53.

PMID:
11786275
33.

In vivo labeling of endothelin receptors with [(11)C]L-753,037: studies in mice and a dog.

Aleksic S, Szabo Z, Scheffel U, Ravert HT, Mathews WB, Kerenyi L, Rauseo PA, Gibson RE, Burns HD, Dannals RF.

J Nucl Med. 2001 Aug;42(8):1274-80.

34.

Use of positron emission tomography to study AT1 receptor regulation in vivo.

Szabo Z, Speth RC, Brown PR, Kerenyi L, Kao PF, Mathews WB, Ravert HT, Hilton J, Rauseo P, Dannals RF, Zheng W, Lee S, Sandberg K.

J Am Soc Nephrol. 2001 Jul;12(7):1350-8.

35.

Biodistribution of [18F] SR144385 and [18F] SR147963: selective radioligands for positron emission tomographic studies of brain cannabinoid receptors.

Mathews WB, Scheffel U, Finley P, Ravert HT, Frank RA, Rinaldi-Carmona M, Barth F, Dannals RF.

Nucl Med Biol. 2000 Nov;27(8):757-62.

PMID:
11150708
36.
37.

Kinetic analysis of [11C]McN5652: a serotonin transporter radioligand.

Szabo Z, Scheffel U, Mathews WB, Ravert HT, Szabo K, Kraut M, Palmon S, Ricaurte GA, Dannals RF.

J Cereb Blood Flow Metab. 1999 Sep;19(9):967-81.

38.

2-[18F]Fluoro-A-85380, an in vivo tracer for the nicotinic acetylcholine receptors.

Horti AG, Scheffel U, Koren AO, Ravert HT, Mathews WB, Musachio JL, Finley PA, London ED, Dannals RF.

Nucl Med Biol. 1998 Oct;25(7):599-603.

PMID:
9804040
39.

Synthesis and evaluation of N-[11C]methylated analogues of epibatidine as tracers for positron emission tomographic studies of nicotinic acetylcholine receptors.

Horti AG, Scheffel U, Kimes AS, Musachio JL, Ravert HT, Mathews WB, Zhan Y, Finley PA, London ED, Dannals RF.

J Med Chem. 1998 Oct 22;41(22):4199-206.

PMID:
9784094
40.

Investigation of angiotensin II/AT1 receptors with carbon-11-L-159,884: a selective AT1 antagonist.

Szabo Z, Kao PF, Burns HD, Gibson RE, Hamill TG, Ravert HT, Kim SE, Mathews WB, Musachio JL, Scheffel U, Dannals RF.

J Nucl Med. 1998 Jul;39(7):1209-13.

41.

Pharmacological evaluation of [11C]A-84543: an enantioselective ligand for in vivo studies of neuronal nicotinic acetylcholine receptors.

Kassiou M, Scheffel UA, Ravert HT, Mathews WB, Musachio JL, London ED, Dannals RF.

Life Sci. 1998;63(1):PL13-8.

PMID:
9667769
42.

In vivo detection of short- and long-term MDMA neurotoxicity--a positron emission tomography study in the living baboon brain.

Scheffel U, Szabo Z, Mathews WB, Finley PA, Dannals RF, Ravert HT, Szabo K, Yuan J, Ricaurte GA.

Synapse. 1998 Jun;29(2):183-92.

PMID:
9593108
43.
44.

N-substituted phenyltropanes as in vivo binding ligands for rapid imaging studies of the dopamine transporter.

Scheffel U, Lever JR, Abraham P, Parham KR, Mathews WB, Kopajtic T, Carroll FI, Kuhar MJ.

Synapse. 1997 Apr;25(4):345-9.

PMID:
9097393
45.

Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography.

Madar I, Lesser RP, Krauss G, Zubieta JK, Lever JR, Kinter CM, Ravert HT, Musachio JL, Mathews WB, Dannals RF, Frost JJ.

Ann Neurol. 1997 Mar;41(3):358-67.

PMID:
9066357
46.

Fenfluramine-induced loss of serotonin transporters in baboon brain visualized with PET.

Scheffel U, Szabo Z, Mathews WB, Finley PA, Yuan J, Callahan B, Hatzidimitriou G, Dannals RF, Ravert HT, Ricaurte GA.

Synapse. 1996 Dec;24(4):395-8.

PMID:
10638827
47.

Imaging of delta opioid receptors in human brain by N1'-([11C]methyl)naltrindole and PET.

Madar I, Lever JR, Kinter CM, Scheffel U, Ravert HT, Musachio JL, Mathews WB, Dannals RF, Frost JJ.

Synapse. 1996 Sep;24(1):19-28.

PMID:
9046073
48.

Development of [11C]L-159,884: a radiolabelled, nonpeptide angiotensin II antagonist that is useful for angiotensin II, AT1 receptor imaging.

Hamill TG, Burns HD, Dannals RF, Mathews WB, Musachio JL, Ravert HT, Naylor EM.

Appl Radiat Isot. 1996 Feb;47(2):211-8.

PMID:
8852629
49.

In vivo labeling of angiotensin II receptors with a carbon-11-labeled selective nonpeptide antagonist.

Kim SE, Scheffel U, Szabo Z, Burns HD, Gibson RE, Ravert HT, Mathews WB, Hamill TG, Dannals RF.

J Nucl Med. 1996 Feb;37(2):307-11.

50.

Positron emission tomography of 5-HT reuptake sites in the human brain with C-11 McN5652 extraction of characteristic images by artificial neural network analysis.

Szabo Z, Kao PF, Mathews WB, Ravert HT, Musachio JL, Scheffel U, Dannals RF.

Behav Brain Res. 1996;73(1-2):221-4.

PMID:
8788506

Supplemental Content

Loading ...
Support Center